Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma As precision medicine ...
SEATTLE--(BUSINESS WIRE)--Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround ...
Copy number variant (CNV) analysis has been part of clinical diagnostics for almost two decades. With the evolution of genomic technologies for CNV detection, we have learned that CNVs can range in ...
Even though the Food and Drug Administration (FDA) has approved more than 200 commercial radiology AI products, substantial obstacles must be overcome before we are likely to see widespread successful ...
Changes in NEN classification in 2013 may partly explain the rise in EOCRC incidence, with NEN rates surging before 2013 and declining thereafter. EOCRC incidence increased among individuals aged 15 ...
On January 29, 2018, the US Food and Drug Administration held a public workshop entitled, “Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology.” Here, we discuss the ...
SEATTLE--(BUSINESS WIRE)--Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results